Compugen Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
Compugen Stock Forecast and Price Target
Compugen's most recent price target of $5.00 for 2024 was provided by four renowned analysts over the past few months, with an average prediction of $5.00. If this prediction is correct, Compugen's stock could rise by 160.42 percent from its current trading price. The potential increase for the stock is $5.00 per share, with a possible range of $4.00 to $7.00. If you are not interested in CGEN stock, you may be interested in its competitors.
160.42% Upside
Compugen Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Compugen's Price has grown by 100.00%, from $0.00 to $0.00. For the next year, analysts are expecting Fair Value to reach $2.04 – an increase of 100.00%. Over the next seven years, experts predict that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MDXG Stock Forecast | MiMedx Group | Buy |
6
|
$6.27 | Buy/Sell | $11.85 | 91.39% |
| OFIX Stock Forecast | Orthofix Medical | Hold |
10
|
$12.99 | Buy/Sell | $18.00 | 15.47% |
| AXGN Stock Forecast | AxoGen | Buy |
6
|
$6.63 | Buy/Sell | $12.50 | 111.16% |
| LCTX Stock Forecast | Lineage Cell Therapeutics | Outperform |
11
|
$1.14 | Buy/Sell | $5.40 | 338.60% |
| MSB Stock Forecast | Mesoblast | Buy |
9
|
$0.93 | Buy/Sell | $0.69 | 18.28% |
Compugen Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Compugen's Revenue has grown by 1573.00%, from $2.00M to $33.46M. According to 3 major analysts, Compugen's Revenue will fall by 87.54% in the next year, reaching $4.17M. Over the next seven years, experts predict that Revenue will grow by 645.46%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XTNT Stock Forecast | Xtant Medical Holdings | Buy |
0
|
$0.95 | Buy/Sell | $1.93 | 103.16% |
| PLUR Stock Forecast | Pluri | - |
9
|
$5.36 | Buy/Sell | $4.00 | -100.00% |
| ATHX Stock Forecast | Athersys | - |
6
|
$0.00 | Buy/Sell | $5.50 | 0.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ISCO Stock Forecast | International Stem Cell | - |
4
|
$0.06 | Buy/Sell | $37.50 | -100.00% |
| PRED Stock Forecast | Predictive Technology Group | - |
0
|
$0.00 | Buy/Sell | $7.00 | 0.00% |
| CRYO Stock Forecast | American CryoStem | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
Compugen EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Compugen's EBITDA has decreased from $-30.78M to $-12.51M – a 59.36% drop. For next year, analysts predict EBITDA of $-19.48M, which would mean an increase of 55.68%. Over the next seven years, experts predict that Compugen's EBITDA will grow at a rate of 154.16%.
Compugen EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Compugen's EBIT has decreased by 58.76%, going from $-31.50M to $-12.99M. In the next year, analysts believe that EBIT will reach $-43.00M – an increase of 231.02%. By 2030, professionals predict that Compugen's EBIT will decrease by 822.02%, to $93.79M.
Compugen EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Compugen's EPS has grown by 100.00%, from $-0.37 to $0.00. For the next year, analysts are expecting EPS to reach $-0.44 – an increase of 100.00%. Over the next seven years, experts predict that EPS will grow by 100.00%.
.jpg)